AKBA Financials
Akebia Therapeutics Inc - Financial statements & key metrics
Stock Price
$1.55
Market Cap
$417.89M
EPS
$-0.02
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$160.18M
Gross Profit
-
Operating Income
-
Net Income
$-69.41M
EPS (Diluted)
$-0.33
Balance Sheet Highlights
Total Assets
$220.67M
Total Liabilities
$269.86M
Shareholders Equity
-
Cash & Equivalents
$51.87M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-40.66M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
82.9%
Operating Margin
-0.1%
Net Margin
-0.0%
ROE
-5.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AKBA revenue?
AKBA's most recent quarterly revenue was $160.18M. Annual revenue can be calculated by summing the four most recent quarters.
Is AKBA profitable?
AKBA reported a loss of $69.41M in the most recent quarter. The net profit margin is -0.0%.
What is AKBA market cap?
AKBA has a market capitalization of $417.89M, making it a small-cap stock.
Does AKBA have debt?
View AKBA's balance sheet for debt information.
What is AKBA cash flow?
Cash flow data is available in the full financial statements.